- Home
- RCKT vs FCRS Comparison
RCKT vs FCRS Comparison
Compare RCKT & FCRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$3.14
Company Overview
Basic Information| Metric | RCKT | FCRS |
|---|---|---|
| Founded | 1999 | 2025 |
| Country | United States | United States |
| Employees | 202 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 401.6M | 367.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RCKT | FCRS |
|---|---|---|
| Price | $3.14 | $10.24 |
| Analyst Decision | Buy | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $29.73 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 42.9K |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $64.28 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.53 | $10.02 |
| 52 Week High | $5.45 | $10.92 |
Technical Indicators
Market Signals| Indicator | RCKT | FCRS |
|---|---|---|
| Relative Strength Index (RSI) | 38.32 | 45.40 |
| Support Level | $2.95 | $10.19 |
| Resistance Level | $3.63 | $10.29 |
| Average True Range (ATR) | 0.16 | 0.02 |
| MACD | -0.06 | -0.00 |
| Stochastic Oscillator | 7.82 | 14.04 |
Price Performance
Historical Comparison RCKT
FCRS
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
About FCRS FutureCrest Acquisition Corp. Class A Ordinary Shares
FutureCrest Acquisition Corp is a blank check company.